About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 289316, 5 pages
http://dx.doi.org/10.1155/2013/289316
Clinical Study

A Study on Clinical and Pathologic Features in Lupus Nephritis with Mainly IgA Deposits and a Literature Review

1Department of Rheumatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
2Department of Nephrology, Peking University People’s Hospital, Beijing 100044, China

Received 2 May 2013; Accepted 19 August 2013

Academic Editor: Xuan Zhang

Copyright © 2013 Liu Hongyan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Weening, V. D. D'Agati, and M. M. Schwartz, “The classification of glomerulonephritis in systemic lupus erythematosus revisited,” Kidney International, vol. 65, pp. 521–530, 2004.
  2. R. N. Verma, A. K. Banerjee, and K. Bhattacharya, “Lupus nephritis-light, electron and immunofluorescent microscopy (a clinicopathological study),” Indian Journal of Pathology and Microbiology, vol. 32, no. 4, pp. 246–251, 1989.
  3. C. Basile, A. Semeraro, A. Montanaro et al., “IgA nephropathy in a patient with systemic lupus erythematosus,” Nephrology Dialysis Transplantation, vol. 13, no. 7, pp. 1891–1892, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Fujikura, T. Kimura, A. Otaka et al., “IgA nephropathy in the patient with systemic lupus erythematosus in remission,” Nihon Naika Gakkai Zasshi, vol. 91, no. 11, pp. 3282–3284, 2002. View at Scopus
  5. A. Corrado, L. Quarta, A. M. Di Palma, L. Gesualdo, and F. P. Cantatore, “IgA nephropathy in systemic lupus erythematosus,” Clinical and Experimental Rheumatology, vol. 25, no. 3, pp. 467–469, 2007. View at Scopus
  6. T. Horino, T. Takao, and Y. Terada, “IgA nephropathy in a patient with systemic lupus erythematosus,” Lupus, vol. 19, no. 5, pp. 650–654, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kobak, O. HudaverdI, G. Keser, and F. Oksel, “Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis and IgA nephropathy in the same patient,” Modern Rheumatology, vol. 21, no. 1, pp. 89–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. F. M. M. Lai, E. K. M. Li, N. L. S. Tang, P. K. T. Li, S. F. Lui, and K. N. Lai, “IgA nephropathy: a rare lesion in systemic lupus erythematosus,” Modern Pathology, vol. 8, no. 1, pp. 5–10, 1995. View at Scopus
  9. E. M. Tan, A. S. Cohen, J. F. Fries et al., “The 1982 revised criteria for the classification of systemic lupus erythrematosus,” Arthritis and Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982. View at Scopus
  10. M. Petri, “Systemic Lupus International Collaborating Clinic (SLICC). SLICC revision of the ACR classification criteria for SLE,” Arthritis and Rheumatism, vol. 60, supplement 10, p. 895, 2009.
  11. N. Bizzaro, E. Tonutti, and D. Villalta, “Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages,” Archives of Pathology and Laboratory Medicine, vol. 129, no. 1, pp. 61–68, 2005. View at Scopus